Kiri Granger
Company: Monument Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Evaluating the Diversity of Biomarkers in Development for Psychosis: The Rationale Behind Biomarker Selection & Where They Fit into R&D for Psychosis Therapeutics 2:30 pm
Audience Q&A with: Alto Neuroscience – Precision Psychiatry PlatformTM Monument Therapeutics – Digital BiomarkerRead more
day: Day One